Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease-Reference-Cited by-同舟云学术

Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease

Published:2015-07-24 Issue:19 Volume:101 Page:1569-1576
ISSN:1355-6037
Container-title:Heart
language:en
Short-container-title:Heart

Author:

Siddiqi Omar K,Smoot Kyle J,Dufour Alyssa B,Cho Kelly,Young Melissa,Gagnon David R,Ly Samantha,Temiyasathit Sara,Faxon David P,Gaziano J Michael,Kinlay Scott

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions;Best;J Am Coll Cardiol,2002

2. Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial;Januzzi;Circulation,2002

3. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry;Latif;JACC Cardiovasc Interv,2009

4. Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study;Naidu;JACC Cardiovasc Interv,2012

5. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention;Naidu;Am J Cardiol,2003

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study;Journal of the American Heart Association;2023-01-17

2. Clinical Outcomes of Prolonged Antiplatelet Therapy after Percutaneous Coronary Intervention in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis;Blood Purification;2022-12-06

3. Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study;Cardiovascular Drugs and Therapy;2022-11-29

4. Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study;Atherosclerosis;2022-07

5. Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome;Journal of Cardiovascular Medicine;2020-06-09